1-4 of 4
Markus Scholz
Close
Sort by
Journal Articles

Genome-Wide Association Study (GWAS) Identifies a Significant Acute Myeloid Leukemia (AML) Susceptibility Locus Near BICRA

Christopher J. Walker, PhD, Christopher C. Oakes, Luke K Genutis, BS, Brian Giacopelli, BS, Sandya Liyanarachchi, MS, Deedra Nicolet, MS, Ann-Kathrin Eisfeld, MD, Markus Scholz, PhD, Pamela Brock, MS, LGC, Jessica Kohlschmidt, PhD, Krzysztof Mrózek, MDPhD, Marius Bill, MD PhD, Andrew J. Carroll, PhD, Jonathan E. Kolitz, MD, Bayard L. Powell, MD, Eunice S. Wang, MD, Dietger Niederwieser, MD, Richard M. Stone, MD, John C. Byrd, MD, Sebastian Schwind, MD, Albert de la Chapelle, MD PhD, Clara D. Bloomfield, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 85.
https://doi.org/10.1182/blood-2018-99-115170
Published: 2018
Journal Articles

CD34 + Donor Chimerism and Wilms Tumor Gene 1 (WT1) Expression Provide an Early Indication of Relapse in Patients with Acute Leukemias and MDS after Hematopoietic Cell Transplantation (HCT) with Reduced-Intensity Conditioning.

Max Hubmann, Ralph Burkhardt, Georg Franke, Michael Cross, Markus Scholz, Sabine Leiblein, Joachim Thiery, Dietger W. Niederwieser, Thoralf Lange
Journal: Blood
Blood (2006) 108 (11): 548.
https://doi.org/10.1182/blood.V108.11.548.548
Published: 2006
Journal Articles

Computational Optimisation of Chemotherapy Regimens Accounting for Heterogeneity of Myelotoxicity - a Worked Example for Lymphoma.

Markus Scholz, PhD, Christoph Engel, MD, Markus Loeffler, MD
Journal: Blood
Blood (2004) 104 (11): 4603.
https://doi.org/10.1182/blood.V104.11.4603.4603
Published: 2004
Journal Articles

A computational model of human granulopoiesis to simulate the hematotoxic effects of multicycle polychemotherapy

Christoph Engel, Markus Scholz, Markus Loeffler
Journal: Blood
Blood (2004) 104 (8): 2323–2331.
https://doi.org/10.1182/blood-2004-01-0306
Published: 2004